Cybin Inc. Unveils Promising Phase 2 Results for Psychedelic Depression Treatment CYB003
Cybin Inc. a psychedelic biotech drug development, has recently announced ...
Venture West Secures $17.5 Million Refinance Loan for Cannabis Firm Cal Grow’s Headquarters
LOS ANGELES- In a significant move underscoring the growing financial ...
Oregon’s Cannabis Market Faces Oversupply Challenges Amid Regulatory Complexities
LOS ANGELES- Oregon, a state known for its progressive stance ...
University of Utah Launches Medical Cannabis Research Center
LOS ANGELES- The University of Utah is taking a significant ...
Numinus Wellness Inc. Announces Fourth Quarter and Full Year Fiscal 2023 Results
LOS ANGELES- Numinus Wellness Inc. has announced its financial results ...
New York Cannabis Control Board Approves Settlement
NEW YORK- In a pivotal decision this week, the New ...
California and Michigan Boost Social Equity in Cannabis Industry with New Funding Initiatives
LOS ANGELES- In a significant move to bolster social equity ...
Clearmind Medicine Inc Reports Promising Results in Pre-Clinical Trial for Combination Therapy
LOS ANGELES- Clearmind Medicine Inc has announced the results of ...
RIV Capital’s Ambitious Transition to Adult-Use Cannabis Sales in New York
LOS ANGELES- RIV Capital, a Toronto-based cannabis investment firm, has ...
Health Canada Approves Jazz Pharmaceuticals’ Epidiolex
NEW YORK- Canada's federal health regulator, Health Canada, has recently ...
